OpenAI Launches GPT-5.5 Bio Bug Bounty Program for AI Safety Research

OpenAI has launched a specialized bug bounty program targeting biological safety risks in its upcoming GPT-5.5 model. The GPT-5.5 Bio Bug Bounty program invites security researchers and domain experts to identify potentially dangerous outputs when the AI system handles life sciences queries.

The program represents OpenAI’s most focused safety initiative yet, concentrating specifically on scenarios where AI-generated content could pose biological risks rather than casting a wide net across all safety concerns.

Biological Risk Focus

The bug bounty specifically targets cases where GPT-5.5 might generate harmful biological information. This includes scenarios where the model could provide detailed instructions for creating dangerous pathogens, synthesizing toxic compounds, or bypassing biosafety protocols in laboratory settings.

OpenAI’s decision to create a biology-specific program suggests the company has identified this as a particularly high-risk application area for large language models. Previous AI safety research has highlighted concerns about models inadvertently becoming tools for bioterrorism or accidental laboratory incidents.

Research Community Participation

The program is open to researchers with relevant expertise in both AI safety and biological sciences. Participants will need to demonstrate knowledge of both domains to effectively identify the intersection points where AI capabilities could create biological risks.

OpenAI hasn’t disclosed the reward structure, but the company’s previous bug bounty programs have offered payments ranging from hundreds to tens of thousands of dollars depending on the severity and novelty of discovered issues.

GPT-5.5 Testing Phase

The bug bounty launch indicates GPT-5.5 is in advanced testing phases, though OpenAI hasn’t announced a public release date. The model appears to have significantly enhanced capabilities in scientific domains, which would explain the need for specialized safety testing.

This pre-release safety testing approach marks a shift from OpenAI’s earlier model launches, where safety evaluations typically occurred closer to public release dates.

Industry Safety Standards

The program aligns with growing industry consensus that AI systems need domain-specific safety evaluation. Rather than generic red-teaming exercises, companies are increasingly running targeted assessments for high-risk applications like healthcare, finance, and biological research.

Other major AI labs have indicated they’re developing similar specialized safety programs, though OpenAI appears to be first to market with a biology-focused bug bounty.

Bottom Line

OpenAI’s bio-focused bug bounty signals both the advanced capabilities of GPT-5.5 and the company’s recognition that powerful AI systems need specialized safety testing. The program should provide valuable data on biological risks before the model reaches researchers and institutions. Whether this approach becomes the new standard for AI safety testing will depend on how effectively it identifies real risks compared to traditional evaluation methods.